Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens

BACKGROUND: Abnormal uterine bleeding (AUB) lowers the quality of life of women. This study attempted to determine which treatment protocol of medroxyprogesterone acetate (MPA), 15 vs 10 day-administration in a luteal phase, provides better outcomes in women with ovulatory dysfunction-related AUB (A...

Descripción completa

Detalles Bibliográficos
Autor principal: Bender, Rukiye Ada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248354/
https://www.ncbi.nlm.nih.gov/pubmed/35746846
http://dx.doi.org/10.12659/MSM.936727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248354/
https://www.ncbi.nlm.nih.gov/pubmed/35746846
http://dx.doi.org/10.12659/MSM.936727

Ejemplares similares